CBER Should Retain Jurisdiction of Assigned Device Reviews – HHS Report

Improved device review times, including speedy handling of West Nile Virus diagnostics, convinced HHS that the Center for Biologics Evaluation & Research should retain jurisdiction over blood and tissue-related devices already assigned to the center

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight